← Back to Clinical Trials
Recruiting NCT07272798

Cardiac Self-Efficacy in Patients With Chronic Thromboembolic Pulmonary Hypertension

Trial Parameters

Condition Chronic Thromboembolic Pulmonary Hypertension
Sponsor Damascus University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 10
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2025-11-20
Completion 2026-11-20

Brief Summary

This study aims to analyze the effect of Pulmonary Endarterectomy (PEA) on patients' self-confidence in managing their chronic illness. Patients' confidence (or self-efficacy) will be measured using the following questionnaires: 10-item Perceived Efficacy in Patient-Physician Interaction Scale (PEPPI), Self-Efficacy for Managing Chronic Diseases 6-item Scale (SEMCD-6), Sullivan's cardiac self-efficacy scale 13-items (SCSES). The association between improved confidence and better physical results will be analyzed, such as being able to walk longer (6 mint walk test (6-Minute Walk Test)). Ultimately, this study will help understanding the psychological side of recovery and might lead to better support programs to help patients feel more capable and live better lives after their operation.

Eligibility Criteria

Inclusion Criteria: * all patients undergoing pulmonary thromboendarterectomy for CTEPH * Able to read and understand the informed consent form and study questionnaires Exclusion Criteria: * Patients undergoing Balloon Pulmonary Angioplasty (BPA) or receiving only medical therapy (as the focus is on the surgical cohort). * Emergency or salvage PEA procedures (to ensure stable baseline assessment). * Inability to complete the questionnaires due to severe cognitive impairment, psychiatric illness, or language barrier.

Related Trials